Teligent Profit Margin 2010-2021 | TLGT

Current and historical gross margin, operating margin and net profit margin for Teligent (TLGT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Teligent net profit margin as of June 30, 2021 is 0%.
Teligent Annual Profit Margins
Teligent Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.440B 5.21
Dr Reddy's Laboratories (RDY) India $12.040B 19.04
Aspen Pharmacare (APNHY) South Africa $5.172B 0.00
BridgeBio Pharma (BBIO) United States $4.408B 0.00
Bausch Health Cos (BHC) Canada $3.088B 2.41
Amphastar Pharmaceuticals (AMPH) United States $1.963B 13.44
Supernus Pharmaceuticals (SUPN) United States $1.626B 0.00
Taysha Gene Therapies (TSHA) United States $0.460B 0.00
Generation Bio (GBIO) United States $0.187B 0.00
Assembly Biosciences (ASMB) United States $0.072B 0.00
Personalis (PSNL) United States $0.064B 0.00
Acasti Pharma (ACST) Canada $0.027B 0.00
Sol-Gel Technologies (SLGL) Israel $0.026B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00